Clinical Trial Update: Tolerability, Safety and Efficacy of Vortioxetine [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing tolerability, safety, and efficacy of vortioxetine for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Depression | Phase 4 | Status: UNKNOWN